SHWGY (Shandong Weigao Group Medical Polymer Co) Total Assets: $5,118 Mil (As of Dec. 2025)


SHWGY Shandong Weigao Group Medical Polymer Co Ltd SHWGY
70 GF Score
Price $1.60
GF Value $3.04
Valuation Significantly Undervalued
! 7 Warning Signs
View Full Analysis

What is Shandong Weigao Group Medical Polymer Co Total Assets?

Shandong Weigao Group Medical Polymer Co SHWGY +6.90% 70 Total Assets is $5,118 Mil as of Dec. 2025. GuruFocus rates SHWGY with a GF Score™ of 70/100 and a GF Value™ of $3.04 (Significantly Undervalued). The stock has 7 warning signs investors should review.

Shandong Weigao Group Medical Polymer Co's Total Assets for the quarter that ended in Dec. 2025 was $5,118 Mil.

During the past 12 months, Shandong Weigao Group Medical Polymer Co's average Total Assets Growth Rate was 4.10% per year. During the past 3 years, the average Total Assets Growth Rate was 0.50% per year. During the past 5 years, the average Total Assets Growth Rate was 1.70% per year. During the past 10 years, the average Total Assets Growth Rate was 9.70% per year.

During the past 13 years, Shandong Weigao Group Medical Polymer Co's highest 3-Year average Total Assets Growth Rate was 48.10%. The lowest was -0.60%. And the median was 22.60%.

Total Assets is connected with ROA %. Shandong Weigao Group Medical Polymer Co's annualized ROA % for the quarter that ended in Dec. 2025 was 3.38%. Total Assets is also linked to Revenue through Asset Turnover. Shandong Weigao Group Medical Polymer Co's Asset Turnover for the quarter that ended in Dec. 2025 was 0.19.


Shandong Weigao Group Medical Polymer Co  (OTCPK:SHWGY) Total Assets Explanation

Total Assets is connected with ROA %.

Shandong Weigao Group Medical Polymer Co's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=171.482/( (5033.452+5118.143)/ 2 )
=171.482/5075.7975
=3.38 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Shandong Weigao Group Medical Polymer Co's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=957.639/( (5033.452+5118.143)/ 2 )
=957.639/5075.7975
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Shandong Weigao Group Medical Polymer Co Total Assets Related Terms


Shandong Weigao Group Medical Polymer Co Total Assets Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Group Medical Polymer Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Group Medical Polymer Co Total Assets Chart

Shandong Weigao Group Medical Polymer Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,800.80 4,791.12 4,715.59 4,774.25 5,118.14

Shandong Weigao Group Medical Polymer Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,715.59 4,761.40 4,774.25 5,033.45 5,118.14
SHWGY
70GF Score
Shandong Weigao Group Medical Polymer Co Ltd SHWGY
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Group Medical Polymer Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Shandong Weigao Group Medical Polymer Co's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (A: Dec. 2025 )+Total Liabilities (A: Dec. 2025 )
=3665.895+1452.249
=5,118

Shandong Weigao Group Medical Polymer Co's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=3665.895+1452.249
=5,118

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $5,118 Mil mean?
Shandong Weigao Group Medical Polymer Co (SHWGY) has a Total Assets of $5,118 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors.
Is Shandong Weigao Group Medical Polymer Co's Total Assets too high?
Shandong Weigao Group Medical Polymer Co's current Total Assets is $5,118 Mil. Overall, Shandong Weigao Group Medical Polymer Co has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Group Medical Polymer Co's Total Assets compare to ISRG and BDX?
Shandong Weigao Group Medical Polymer Co's Total Assets of $5,118 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Shandong Weigao Group Medical Polymer Co and its competitors. Shandong Weigao Group Medical Polymer Co's current Total Assets is $5,118 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Group Medical Polymer Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co (SHWGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $3.04, compared to a current price of $1.60 — trading 47.5% below its estimated fair value. The current Total Assets is $5,118 Mil. Shandong Weigao Group Medical Polymer Co's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Shandong Weigao Group Medical Polymer Co (SHWGY), the current Total Assets is $5,118 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Weigao Group Medical Polymer Co (SHWGY) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Weigao Group Medical Polymer Co stock appears to be undervalued. The current stock price of $1.60 is trading 47.5% below its estimated GF Value™ of $3.04. GuruFocus considers Shandong Weigao Group Medical Polymer Co to be Significantly Undervalued.

Key valuation signals for SHWGY:

  • Total Assets: $5,118 Mil
  • GF Value™: $3.04 vs. price of $1.60 (47.5% below fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the SHWGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Weigao Group Medical Polymer Co Business Description

Address No.1, Weigao Road, Torch Hi-tech Science Park, Shandong Province, Weihai, CHN
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.
70GF Score

Get the complete analysis for SHWGY

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.60
Price
$3.04
GF Value